Manifestations of Stroke

Editor(s): Paciaroni, M. (Perugia)
Agnelli, G. (Perugia)
Caso, V. (Perugia)
Bogousslavsky, J. (Montreux)

Topographic Syndromes

Cerebellar Infarcts and Hemorrhages

Venti M.

Author affiliations

Stroke Unit and Division of Internal and Cardiovascular Medicine, University of Perugia, Santa Maria della Misericordia Hospital, Perugia, Italy

Related Articles for ""

Paciaroni M, Agnelli G, Caso V, Bogousslavsky J (eds): Manifestations of Stroke. Front Neurol Neurosci. Basel, Karger, 2012, vol 30, pp 171-175

Log in to MyKarger to check if you already have access to this content.


Buy

  • FullText & PDF
  • Unlimited re-access via MyKarger
  • Unrestricted printing, no saving restrictions for personal use
read more

CHF 38.00 *
EUR 35.00 *
USD 39.00 *

Select

KAB

Buy a Karger Article Bundle (KAB) and profit from a discount!


If you would like to redeem your KAB credit, please log in.


Save over 20% compared to the individual article price.

Learn more

Rent/Cloud

  • Rent for 48h to view
  • Buy Cloud Access for unlimited viewing via different devices
  • Synchronizing in the ReadCube Cloud
  • Printing and saving restrictions apply

Rental: USD 8.50
Cloud: USD 20.00

Select

Complete book

  • Immediate access to all parts of this book
  • Cover-to-cover formats may be available
  • Unlimited re-access via MyKarger
  • Unrestricted printing, no saving restriction for personal use
read more

Pricing depends on hard-cover price


Select

* The final prices may differ from the prices shown due to specifics of VAT rules.

Article / Publication Details

First-Page Preview
Abstract of Topographic Syndromes

Published online: February 14, 2012
Cover Date: 2012

Number of Print Pages: 5
Number of Figures: 1
Number of Tables: 0

ISBN: 978-3-8055-9910-8 (Print)
eISBN: 978-3-8055-9911-5 (Online)

Abstract

Cerebellar infarction accounts for about 3.4% of all ischemic strokes. Cerebellar syndromes are principally characterized by cerebellar symptoms and signs which depend on the involved vascular territories. In the Perugia Stroke Registry, infarct areas have included the superior cerebellar artery region in 36% of patients, the anterior inferior cerebellar artery region in 12%, and the posterior inferior cerebellar artery region in 40%; 12% of patients have had multiple vascular region involvement. 50% of the patients have had concurrent brainstem infarcts. Cerebellar hemorrhage accounts for about 10% of all intracranial hemorrhages and about 10% of all cerebellar strokes. Both stroke types can be worsened by complications due to a significant mass effect and brainstem compression. These events can lead to clinical deterioration which induces stupor and coma with a very high fatality rate.

© 2012 S. Karger AG, Basel




Related Articles:


References

  1. Edlow JA, Newman-Toker DE, Savitz SI: Diagnosis and initial management of cerebellar infarction. Lancet Neuro 2008;7:951-964
  2. Amarenco P: Cerebellar stroke syndrome. (eds) Bogousslavsky J, Caplan LR: Stroke Syndrome 2Cambridge, Cambridge University Press, 1991;540-556
  3. Mohr JP, Caplan LR: Vertebrobasilar disease. (eds) Bamett HJM, Stein BM, Mohr JP, Yatsu FM: Stroke. Pathophysiology, diagnosis, and Managemen 2New York, Churchill Livingstone, 1992;

Article / Publication Details

First-Page Preview
Abstract of Topographic Syndromes

Published online: February 14, 2012
Cover Date: 2012

Number of Print Pages: 5
Number of Figures: 1
Number of Tables: 0

ISBN: 978-3-8055-9910-8 (Print)
eISBN: 978-3-8055-9911-5 (Online)


Copyright / Drug Dosage / Disclaimer

Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
TOP